Cell and gene therapy

#Autoimmune disease #CAR-T #Cell and gene therapy #Cell therapy

Expanding access to cell therapies for autoimmune conditions

DDW Editor Reece Armstrong speaks to Fred Aslan, MD, President and Chief Executive Officer of Artiva Biotherapeutics about how to scale-up access to cell and gene therapies for patients suffering from autoimmune diseases. The rise of cell therapies in the past decade has led to meaningful clinical responses across both… Read More

#Exclusive Content

#Automated workflows #Automation #Automation / robotics #Case study #Cell and gene therapy #Cellular assays #Viral vectors

Case study: Automating cell-based assays

A new Case Study is now available to download from Hamilton. Oxford Biomedica is an innovative leading viral vector specialist focused on delivering life-changing therapies to patients. The company works across key viral vector delivery systems (lentiviral-, adeno-associated viral- and adenoviral-based vector systems), providing innovative solutions to cell and gene… Read More

#News

#Automated workflows #Automation #Automation / robotics #Cell and gene therapy #Cellular assays #Viral vectors

Automating cell-based assays to determine viral vector titer

In this Case Study, Oxford Biomedica, an innovative global gene and cell therapy company, describes: The automated system used for a 10-day cell-based workflow required for an analytical test to determine viral vector titer The advantages of Hamilton’s CECULA Graphical User Interface (GUI) for the planning of long-term cell-based assays… Read More

#Resources

#CAR-T #Cell and gene therapy #Cell therapy #Gene therapy

New DDW Highlights episode: 16 December 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It’s been a big week for cell and gene therapies… Read More

#News

#CAR-T #Cell and gene therapy #Cell therapy #Gene therapy

This week in drug discovery (9-13 December) 

News round-up for 9-13 December by DDW Senior Digital Content Editor Diana Spencer. It’s been a big week for cell and gene therapies (CGTs) as the first in vivo BCMA CAR-T candidate reaches the clinic and a new discovery could lead to a gene therapy that reverses a… Read More

#News

#Advanced Therapies #Cell and gene therapy #Laboratory #Medical Research Council

MRC launches new £50m UK centres to develop gene therapies

The Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases.   The new UK centres will receive up to £50 ($63.8) million each over 14 years.  They will aim to build on… Read More

#Business & Investment #News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Don’t miss out: Last chance to register for the DDW CGT Showcase

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Webinar: Overcome the challenges of developing CGTs

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Register now: Discover areas of opportunity in CGT drug discovery

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

What will the future bring in cell and gene therapies?

Join the DDW Cell & Gene Therapy Showcase on 21 November at 2pm GMT, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery and… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Webinar

Register now for DDW’s Cell & Gene Therapy Showcase

Join the DDW Cell & Gene Therapy Showcase, a free online event hosted by DDW and supported by Benchling, Sartorius, Applied StemCell, and Elegen Bio. In this free online event leading industry figures will outline areas of opportunity in CGT drug discovery & development sector as well as highlighting challenges… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene editing #Gene therapy

Cell & Gene Therapy Showcase

In this free online event leading industry figures outline areas of opportunity in CGT drug discovery and development sector as well as highlighting challenges facing the industry and how they can be overcome. It features presentations from experts in the field of cell and gene therapy drug development as well… Read More

Webinar date:
Co-sponsored by Benchling, Sartorius, Applied StemCell, and Elegen Bio
#Webinars

Cell and gene therapy concept
#Cell and gene therapy #Cell therapy #Gene therapy #RNA

What are the challenges and advancements driving CGT drug development?

In this webinar you will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and Gerard Caelles, CBO at Splice Bio. Erik Wiklund will discuss how circular RNA is crucial to the development of next-generation cell and gene therapy products. Ali Pashazadeh will explore current barriers… Read More

Webinar date:
Sponsored by Benchling and Applied StemCell
#Webinars

#Cell and gene therapy #Cell therapy #Gene therapy #RNA #Webinar

Webinar: Understand the challenges and advances driving CGTs

In this webinar on 8 October 3-4PM BST, hosted by DDW and sponsored by Benchling, you will learn about the challenges and advancements driving drug development for cell and gene therapies. You will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and… Read More

Webinar date:
Sponsored by Benchling
#News

#Cell and gene therapy #Cell therapy #Gene therapy #RNA

Webinar: Learn about the challenges for cell and gene therapies

In this webinar on 8 October 3-4PM BST, hosted by DDW and sponsored by Benchling, you will learn about the challenges and advancements driving drug development for cell and gene therapies. You will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and… Read More

Webinar date:
Sponsored by Benchling
#News

#Biology #Cell and gene therapy #Cell therapy #Financing #Harvard Medical School #iPSC

Cell therapy company GC Therapeutics launches with $75m 

GC Therapeutics (GCTx) has launched with $75 million in total capital.  GCTx’s induced pluripotent stem cell (iPSC) programming platform, TFome (Transcription-Factor-ome), was invented and developed by scientists in the lab of Professor George Church at Harvard Medical School and the Wyss Institute.  It integrates synthetic biology, gene editing, cell engineering… Read More

#Business & Investment #News